Peptide binding characteristics of the coeliac disease-associated DQ(alpha10501, beta10201) molecule - PubMed (original) (raw)

Peptide binding characteristics of the coeliac disease-associated DQ(alpha1*0501, beta1*0201) molecule

Y van de Wal et al. Immunogenetics. 1996.

Abstract

Genetic susceptibility to coeliac disease (CD) is strongly associated with the expression of the HLA-DQ2 (alpha1(*)0501, beta1(*)0201) allele. There is evidence that this DQ2 molecule plays a role in the pathogenesis of CD as a restriction element for gliadin-specific T cells in the gut. However, it remains largely unclear which fragments of gliadin can actually be presented by the disease-associated DQ dimer. With a view to identifying possible CD-inducing antigens, we studied the peptide binding properties of DQ2. For this purpose, peptides bound to HLA-DQ2 were isolated and characterized. Dominant peptides were found to be derived from two self-proteins: in addition to several size-variants of the invariant chain (li)-derived CLIP peptide, a relatively large amount of an major histocompatibility complex (MHC) class I-derived peptide was found. Analogues of this naturally processed epitope (MHClalpha46 - 63) were tested in a cell-free peptide binding competition assay to investigate the requirements for binding to DQ2. First, a core sequence of 10 amino acids within the MHClalpha46 - 63 peptide was identified. By subsequent single amino acid substitution analysis of this core sequence, five putative anchor residues were identified at relative positions P1, P4, P6, P7, and P9. Replacement by the large, positively charged Lys at these positions resulted in a dramatic loss of binding. However, several other non-conservative substitutions had little or no discernable effect on the binding capacity of the peptides.

PubMed Disclaimer

Similar articles

• Both alpha and beta chain polymorphisms determine the specificity of the disease-associated HLA-DQ2 molecules, with beta chain residues being most influential.
  Johansen BH, Jensen T, Thorpe CJ, Vartdal F, Thorsby E, Sollid LM. Johansen BH, et al. Immunogenetics. 1996;45(2):142-50. doi: 10.1007/s002510050182. Immunogenetics. 1996. PMID: 8952964
• The peptide binding motif of the disease associated HLA-DQ (alpha 1* 0501, beta 1* 0201) molecule.
  Vartdal F, Johansen BH, Friede T, Thorpe CJ, Stevanović S, Eriksen JE, Sletten K, Thorsby E, Rammensee HG, Sollid LM. Vartdal F, et al. Eur J Immunol. 1996 Nov;26(11):2764-72. doi: 10.1002/eji.1830261132. Eur J Immunol. 1996. PMID: 8921967
• Unique peptide binding characteristics of the disease-associated DQ(alpha 1*0501, beta 1*0201) vs the non-disease-associated DQ(alpha 1*0201, beta 1*0202) molecule.
  van de Wal Y, Kooy YM, Drijfhout JW, Amons R, Papadopoulos GK, Koning F. van de Wal Y, et al. Immunogenetics. 1997;46(6):484-92. doi: 10.1007/s002510050309. Immunogenetics. 1997. PMID: 9321428
• On the perils of poor editing: regulation of peptide loading by HLA-DQ and H2-A molecules associated with celiac disease and type 1 diabetes.
  Busch R, De Riva A, Hadjinicolaou AV, Jiang W, Hou T, Mellins ED. Busch R, et al. Expert Rev Mol Med. 2012 Jul 6;14:e15. doi: 10.1017/erm.2012.9. Expert Rev Mol Med. 2012. PMID: 22805744 Free PMC article. Review.
• HLA-DQ genetics in children with celiac disease: a meta-analysis suggesting a two-step genetic screening procedure starting with HLA-DQ β chains.
  De Silvestri A, Capittini C, Poddighe D, Valsecchi C, Marseglia G, Tagliacarne SC, Scotti V, Rebuffi C, Pasi A, Martinetti M, Tinelli C. De Silvestri A, et al. Pediatr Res. 2018 Mar;83(3):564-572. doi: 10.1038/pr.2017.307. Epub 2018 Jan 17. Pediatr Res. 2018. PMID: 29244800

Cited by

• Celiac disease T-cell epitopes from gamma-gliadins: immunoreactivity depends on the genome of origin, transcript frequency, and flanking protein variation.
  Salentijn EM, Mitea DC, Goryunova SV, van der Meer IM, Padioleau I, Gilissen LJ, Koning F, Smulders MJ. Salentijn EM, et al. BMC Genomics. 2012 Jun 22;13:277. doi: 10.1186/1471-2164-13-277. BMC Genomics. 2012. PMID: 22726570 Free PMC article.
• Targeted modification of wheat grain protein to reduce the content of celiac causing epitopes.
  Osorio C, Wen N, Gemini R, Zemetra R, von Wettstein D, Rustgi S. Osorio C, et al. Funct Integr Genomics. 2012 Aug;12(3):417-38. doi: 10.1007/s10142-012-0287-y. Epub 2012 Jun 26. Funct Integr Genomics. 2012. PMID: 22732824 Review.
• Soluble HLA-DQ2 expressed in S2 cells copurifies with a high affinity insect cell derived protein.
  Jüse U, Fleckenstein B, Bergseng E, Sollid LM. Jüse U, et al. Immunogenetics. 2009 Feb;61(2):81-9. doi: 10.1007/s00251-008-0338-7. Epub 2008 Nov 6. Immunogenetics. 2009. PMID: 18987854
• Coeliac Disease Pathogenesis: The Uncertainties of a Well-Known Immune Mediated Disorder.
  Dunne MR, Byrne G, Chirdo FG, Feighery C. Dunne MR, et al. Front Immunol. 2020 Jul 8;11:1374. doi: 10.3389/fimmu.2020.01374. eCollection 2020. Front Immunol. 2020. PMID: 32733456 Free PMC article. Review.
• Specificity of tissue transglutaminase explains cereal toxicity in celiac disease.
  Vader LW, de Ru A, van der Wal Y, Kooy YM, Benckhuijsen W, Mearin ML, Drijfhout JW, van Veelen P, Koning F. Vader LW, et al. J Exp Med. 2002 Mar 4;195(5):643-9. doi: 10.1084/jem.20012028. J Exp Med. 2002. PMID: 11877487 Free PMC article.

References

1. 1. Int Immunol. 1994 Nov;6(11):1639-49 - PubMed
2. 1. J Exp Med. 1994 Aug 1;180(2):623-9 - PubMed
3. 1. J Exp Med. 1993 Jul 1;178(1):27-47 - PubMed
4. 1. Br J Rheumatol. 1991 Feb;30(1):5-9 - PubMed
5. 1. J Biol Chem. 1987 Nov 25;262(33):16087-94 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Springer

• Other Literature Sources

  • The Lens - Patent Citations Database

• Medical

  • MedlinePlus Health Information

• Molecular Biology Databases

  • Immune Epitope Database and Analysis Resource

• Research Materials

  • NCI CPTC Antibody Characterization Program